These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 9699900)

  • 1. Genetic variation in paraoxonase-1 and paraoxonase-2 is associated with variation in plasma lipoproteins in Alberta Hutterites.
    Boright AP; Connelly PW; Brunt JH; Scherer SW; Tsui LC; Hegele RA
    Atherosclerosis; 1998 Jul; 139(1):131-6. PubMed ID: 9699900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic variation in paraoxonase-2 is associated with variation in plasma lipoproteins in Canadian Oji-Cree.
    Hegele RA; Harris SB; Connelly PW; Hanley AJ; Tsui LC; Zinman B; Scherer SW
    Clin Genet; 1998 Nov; 54(5):394-9. PubMed ID: 9842991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple genetic determinants of variation of plasma lipoproteins in Alberta Hutterites.
    Hegele RA; Brunt JH; Connelly PW
    Arterioscler Thromb Vasc Biol; 1995 Jul; 15(7):861-71. PubMed ID: 7600118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus.
    Hegele RA; Connelly PW; Scherer SW; Hanley AJ; Harris SB; Tsui LC; Zinman B
    J Clin Endocrinol Metab; 1997 Oct; 82(10):3373-7. PubMed ID: 9329371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between PON1 L/M55 polymorphism and plasma lipoproteins in two Canadian aboriginal populations.
    Fanella S; Harris SB; Young TK; Hanley AJ; Zinman B; Connelly PW; Hegele RA
    Clin Chem Lab Med; 2000 May; 38(5):413-20. PubMed ID: 10952224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism of the paraoxonase gene associated with variation in plasma lipoproteins in a genetic isolate.
    Hegele RA; Brunt JH; Connelly PW
    Arterioscler Thromb Vasc Biol; 1995 Jan; 15(1):89-95. PubMed ID: 7749820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase genes and disease.
    Hegele RA
    Ann Med; 1999 Jun; 31(3):217-24. PubMed ID: 10442677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy.
    Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI
    Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.
    Sanghera DK; Aston CE; Saha N; Kamboh MI
    Am J Hum Genet; 1998 Jan; 62(1):36-44. PubMed ID: 9443862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association and linkage of LDLR gene variation with variation in plasma low density lipoprotein cholesterol.
    Boright AP; Connelly PW; Brunt JH; Morgan K; Hegele RA
    J Hum Genet; 1998; 43(3):153-9. PubMed ID: 9747026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common genomic variation in the APOC3 promoter associated with variation in plasma lipoproteins.
    Hegele RA; Connelly PW; Hanley AJ; Sun F; Harris SB; Zinman B
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2753-8. PubMed ID: 9409252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene.
    Pan JP; Lai ST; Chiang SC; Chou SC; Chiang AN
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Sep; 65(9):415-21. PubMed ID: 12433026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients.
    Leus FR; Zwart M; Kastelein JJ; Voorbij HA
    Atherosclerosis; 2001 Feb; 154(3):641-9. PubMed ID: 11257265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Codon 311 (Cys --> Ser) polymorphism of paraoxonase-2 gene is associated with apolipoprotein E4 allele in both Alzheimer's and vascular dementias.
    Janka Z; Juhász A; Rimanóczy A A; Boda K; Márki-Zay J; Kálmán J
    Mol Psychiatry; 2002; 7(1):110-2. PubMed ID: 11803456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants APOC3, APOA5, APOE and PON1 are associated with variation in plasma lipoprotein traits in Greenlanders.
    Lahiry P; Ban MR; Pollex RL; Feldman RD; Sawyez CG; Huff MW; Young TK; Bjerregaard P; Hegele RA
    Int J Circumpolar Health; 2007 Dec; 66(5):390-400. PubMed ID: 18274205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study.
    Senti M; Tomás M; Elosual R; Sala J; Masiá R; Marrugat J
    Clin Chem Lab Med; 2002 Jul; 40(7):677-83. PubMed ID: 12241013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipoprotein-genotype associations in Trinidadian neonates.
    Hegele RA; Ban MR; Busch CP; Ramsewak S; Ramdath DD
    Clin Biochem; 1999 Aug; 32(6):429-37. PubMed ID: 10667478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic variations of the paraoxonase gene in patients with coronary artery disease.
    Hong SH; Song J; Min WK; Kim JQ
    Clin Biochem; 2001 Sep; 34(6):475-81. PubMed ID: 11676977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family.
    Primo-Parmo SL; Sorenson RC; Teiber J; La Du BN
    Genomics; 1996 May; 33(3):498-507. PubMed ID: 8661009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Common genomic variants associated with variation in plasma lipoproteins in young aboriginal Canadians.
    Hegele RA; Connelly PW; Hanley AJ; Sun F; Harris SB; Zinman B
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1060-6. PubMed ID: 9194755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.